Skip to content

Welcome to Discover Pharma! Today is : October 23, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Liza

  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    FDA seeks input on new rare disease drug development framework

    The FDA is seeking public feedback on plans to tailor [...]

    October 23, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Cabenuva real-world study reports sustained HIV viral suppression

    A US observational study of nearly 7,000 adults with HIV-1 [...]

    October 23, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    AmplexDiagnostics launches rapid Candida auris resistance test

    AmplexDiagnostics has launched a CE-IVD molecular diagnostic test that detects [...]

    October 21, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    SeaBeLife secures €2.9m to advance acute liver injury drug

    SeaBeLife has secured €2.9 million in French government funding to [...]

    October 21, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Gesynta Pharma completes recruitment in endometriosis trial

    Gesynta Pharma has completed recruitment for its Phase 2 trial [...]

    October 21, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    AltruBio reports early ulcerative colitis data for ALTB-268

    AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

    October 21, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Survey finds patient groups are split on involvement in drug pricing

    Nearly half of surveyed patient groups say they engage with [...]

    October 21, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Johnson & Johnson reports three-year Crohn’s disease results for guselkumab

    Johnson & Johnson has reported three-year clinical remission data for [...]

    October 20, 2026
  • Drug Discovery & Development,Research & Development

    Ryvu reports preclinical results for novel ADC payload

    Ryvu Therapeutics has reported preclinical results for RVU602, an experimental [...]

    October 19, 2026
  • Manufacturing & Supply Chain

    Kindeva wins $226 million contract for nerve agent antidote autoinjectors

    Kindeva’s global health security division has been awarded a contract [...]

    October 19, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • NICE recommends maralixibat for Alagille syndrome itching
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Mursla Bio validates liver-specific liquid biopsy platform
    Categories: Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • E2 secures FDA clearance for pulmonary embolism thrombectomy system
    Categories: Clinical & Regulatory, Medical devices
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top